NorthStar Medical Radioisotopes LLC has been awarded three patents and a trademark approval from the United States Patent and Trademark Office.

Patents were granted for the RadioGenix™ isotope separation system and two of its key components – the Molybdenum-99 (Mo-99) Source Vessel and the Technetium-99m (Tc-99m) Product Cartridge. A trademark was awarded for NuMolium™, the company’s brand of Mo-99.

To read more please visit: http://www.businesswire.com/news/home/20160610005221/en/

Source: Sputnik International